Gritstone bio, Inc. (GRTS) Financials

GRTS Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 177.8 million 125.9 million
2023-09-30 187.2 million 113.2 million
2023-06-30 222.6 million 113.1 million
2023-03-31 210.0 million 69.1 million

GRTS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -34.6 million 2.8 million
2023-09-30 -32.2 million 3.0 million
2023-06-30 -32.7 million 2.9 million
2023-03-31 -41.7 million 2.9 million

GRTS Net Income

No data available :(

GRTS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 81.6 million - 64.6 million
2023-09-30 83.9 million - 65.4 million
2023-06-30 114.5 million 29.7 million 65.7 million
2023-03-31 145.8 million 29.6 million 19.2 million

GRTS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 97.6 million
2023-09-30 115.3 million
2023-06-30 114.9 million
2023-03-31 114.4 million

GRTS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 191000 32.9 million 7.9 million 1.9 million
2023-09-30 1.1 million 32.8 million 7.4 million -
2023-06-30 1.7 million 31.0 million 6.7 million -
2023-03-31 1.6 million 30.5 million 6.7 million -

GRTS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 29000 1.9 million
2023-09-30 1.6 million 2.0 million
2023-06-30 400000 1.6 million
2023-03-31 542000 30.5 million

GRTS

Price: $0.96

52 week price:
0.74
3.33

Earnings Per Share: -1.20 USD

P/E Ratio: -1.82

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 427892

Market Capitalization: 95.1 million

Links: